<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Trends in Phytochemical Research</JournalTitle>
<Issn>2588-3631</Issn>
<Volume>5</Volume>
<Issue>4</Issue>
<PubDate PubStatus="epublish">
<Year>2021</Year>
<Month>12</Month>
<Day>01</Day>
</PubDate>
</Journal>
<ArticleTitle>Arq ajwain protects nonalcoholic fatty liver disease on high-fat diet-induced obese rat</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage>209</FirstPage>
<LastPage>221</LastPage>
<ELocationID EIdType="doi"></ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Md Rafiul</FirstName>
<LastName>Haque</LastName>
<Affiliation>School of Pharmacy, Al-Karim University, Bihar, India|School of Pharmaceutical Education and Research, Hamdard University, Hamdard Nagar, New Delhi 62, India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Md Afroz</FirstName>
<LastName>Ahmad</LastName>
<Affiliation>Department of Prmhacology, Integral University, Lucknow (U.P), India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Kamran</FirstName>
<LastName>Ashraf</LastName>
<Affiliation>Faculty of Pharmacy, University Teknologi MARA (UITM), Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malasiya</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Md Habban</FirstName>
<LastName>Akhter</LastName>
<Affiliation>School of Pharmaceutical and population Health information (SoPPHI), DIT University, Dehradun 248009, India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Mohammad</FirstName>
<LastName>Jameel</LastName>
<Affiliation>RRIUM, CCRUM Aligarh (UP), India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Abuzer</FirstName>
<LastName>Ali</LastName>
<Affiliation>Department of Pharmacognosy, College of Pharmacy, Taif University, P.O. box 21944, Saudi Arabia</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Wasim</FirstName>
<LastName>Akhtar</LastName>
<Affiliation>School of Pharmacy, Al-Karim University, Bihar, India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Monika</FirstName>
<LastName>Dhaka</LastName>
<Affiliation>School of Pharmaceutical and population Health information (SoPPHI), DIT University, Dehradun 248009, India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Kavita</FirstName>
<LastName>Rana</LastName>
<Affiliation>Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida (UP), India</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2021</Year>
<Month>12</Month>
<Day>01</Day>
</PubDate>
</History>
<Abstract>In the present study, we investigated the safety and therapeutic efficacy of arq ajwain (AA) against nonalcoholic fatty liver disease (NAFLD) on a high-fat diet (HFD) induced obese rat model. After 4 weeks of the treatment, AA (4 mL/kg, twice a day) and AA1 (7.75 mL/kg, twice a day) treatments reduced body weight, serum triglycerides (TG), total cholesterol (TG), glucose, insulin, leptin, pancreatic lipase activity and alanine aminotransferase (ALT) levels (p &amp;lt; 0.001). AA, AA1, and thymol (T) treatments also decreased lipids (TG and TC) levels and increased thiobarbituric acid reactive substances (TBARS), superoxide dismutase (SOD), and catalase (CAT) levels in hepatic tissue (p &amp;lt; 0.001). Moreover, treatment groups considerably reduced hepatic inflammation, steatosis, hepatocellular ballooning, and fibrosis. These results recommend that arq ajwain has a strong protective effect against NAFLD in HFD induced obese rat models.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">Ajwain</Param>
</Object>
<Object Type="keyword">
<Param Name="value">insulin</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Oxidative stress</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Leptin</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Nonalcoholic fatty liver disease</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>